Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | RXRA |
| Upstream (Parents) |
|---|
| (<<) ADRBK2 → RXRA |
| (<<) CISH → RXRA |
| (<<) CYB5R3 → RXRA |
| (<<) GNG5 → RXRA |
| (<<) IL1A → RXRA |
| (<<) MAP3K11 → RXRA |
| (<<) MAPK3 → RXRA |
| (<<) MKNK2 → RXRA |
| (<<) PAK4 → RXRA |
| (<<) PDE4C → RXRA |
| (<<) PPP1R11 → RXRA |
| (<<) PRKCSH → RXRA |
| (<<) PTEN → RXRA |
| (<<) RARA → RXRA |
| (<<) SF3A2 → RXRA |
| (<<) SH3GL1 → RXRA |
| (<<) SH3GLB2 → RXRA |
| (<<) SLC20A1 → RXRA |
| (<<) UBE2D3 → RXRA |
| (<<) VAC14 → RXRA |
| Downstream (Children) |
|---|
| RXRA → ARSA (>>) |
| RXRA → BCL3 (>>) |
| RXRA → CDC42EP1 (>>) |
| RXRA → CDKN1A (>>) |
| RXRA → CHAC1 (>>) |
| RXRA → EFNB1 (>>) |
| RXRA → FAM129B (>>) |
| RXRA → FAM48A (>>) |
| RXRA → FLJ35934 (>>) |
| RXRA → GPRIN1 (>>) |
| RXRA → GYS1 (>>) |
| RXRA → INVS (>>) |
| RXRA → KLF16 (>>) |
| RXRA → LOC92249 (>>) |
| RXRA → LRP3 (>>) |
| RXRA → MAPK7 (>>) |
| RXRA → MYL5 (>>) |
| RXRA → PIK3R2 (>>) |
| RXRA → PRKAA1 (>>) |
| RXRA → RAB15 (>>) |
| RXRA → RPS6KA3 (>>) |
| RXRA → RRP15 (>>) |
| RXRA → TMEM39B (>>) |
| RXRA → TNRC18 (>>) |
| RXRA → TRAF2 (>>) |
| RXRA → TYRO3 (>>) |
| RXRA → UBQLN1 (>>) |
| RXRA → VANGL1 (>>) |
| RXRA → VPS37B (>>) |
| RXRA → ZFPM1 (>>) |
